Quetiapine XR monotherapy and quetiapine XR+ongoing antidepressant versus lithium+ongoing AD for Stage II treatment-resistant major depressive disorder

Authors
Category Primary study
ConferencePublished in: European Neuropsychopharmacology
Year 2010
This article has no abstract
Epistemonikos ID: 889b0841e2855741d22982827d94c30f8ffae8d5
First added on: Nov 15, 2018